Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference
07 May 2015 - 2:00AM
Amedisys, Inc. (Nasdaq:AMED), one of America’s leading healthcare
at home companies, today announced that Paul B. Kusserow, President
and Chief Executive Officer, will present at the 2015 Bank of
America Merrill Lynch Health Care Conference in Las Vegas, NV on
Tuesday, May 12, 2015.
The presentation will begin at 8:00 a.m. Pacific/11:00 p.m.
Eastern. To access a live webcast of the Amedisys
presentation, please log on through our website at
http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. (Nasdaq:AMED) is a leading health care at home
company delivering personalized home health and hospice care to
approximately 360,000 patients each year. Amedisys is focused on
delivering the care that is best for our patients, whether that is
home-based recovery and rehabilitation after an operation or
injury, care focused on empowering them to manage a chronic
disease, palliative care for those with a terminal illness, or
hospice care at the end of life. The Company's state-of-the-art
advanced chronic care management programs and leading-edge
technology enables it to deliver quality care based upon the latest
evidence-based best practices. Amedisys is a recognized innovator,
being one of the first in the industry to equip its clinicians with
point-of-care laptop technology and referring physicians with an
internet portal that enables real-time coordination of patient care
seamlessly. Amedisys also has the industry's first-ever nationwide
Care Transitions program, designed to reduce unnecessary hospital
readmissions through patient and caregiver health coaching and care
coordination, which starts in the hospital and continues throughout
completion of the patient's home health plan of care. For more
information about the Company, please visit:
http://www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, analyst presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. We will also use our website to expedite
public access to time-critical information regarding the Company in
advance of or in lieu of distributing a press release or a filing
with the Securities and Exchange Commission ("SEC") disclosing the
same information. In addition, we make available on the Investor
Relations subpage of our website (under the link "SEC filings")
free of charge our annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, ownership reports on
Forms 3, 4 and 5 and any amendments to those reports as soon as
practicable after we electronically file such reports with the SEC.
Further, copies of our Certificate of Incorporation and Bylaws, our
Code of Ethical Business Conduct and the charters for the Audit,
Compensation, Nominating and Corporate Governance, Quality of Care
and Compliance and Ethics Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
Contact:
Amedisys, Inc.
David Castille
Managing Director, Finance
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2024 to May 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From May 2023 to May 2024